ArticleAlimentary pharmacology & therapeutics2026
Asian Patients Report Higher Reflux Symptom Burden than US Patients Despite Lower Objective Reflux Burden.
Article in Alimentary pharmacology & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Letter: From Regional Diagnostic Thresholds to Phenotype-Guided Management in Asian Reflux Disease.Alimentary pharmacology & therapeutics · 2026Article
- Letter: From Regional Diagnostic Thresholds to Phenotype-Guided Management in Asian Reflux Disease. Authors' Reply.Alimentary pharmacology & therapeutics · 2026Article
- Asian Patients Report Higher Reflux Symptom Burden than US Patients Despite Lower Objective Reflux Burden.Alimentary pharmacology & therapeutics · 2026Article
- Editorial: Do We Need to Adapt GERD Metrics Based on the Population Being Evaluated?Alimentary pharmacology & therapeutics · 2026Article
- Editorial: Do we Need to Adapt GERD Metrics Based on the Population Being Evaluated? Authors' Reply.Alimentary pharmacology & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSymptoms and reflux burden in gastroesophageal reflux disease (GERD) may vary between populations.
aimsTo evaluate relationships between symptom profiles and objective reflux burden in patients in two world regions, Asia and the United States.
methodsThis was a cross-sectional study of patients undergoing pH-impedance monitoring from one Asian and two US centres. Validated patient-reported symptom instruments were prospectively collected. Symptom characteristics were compared against objective reflux burden (acid exposure time, AET; total reflux episodes, TRE; mean nocturnal baseline impedance, MNBI) from pH-impedance monitoring between the two populations.
resultsOf 1099 patients, 162 were in Asia (age 47.4 ± 1.1 years, 36.4% female, body mass index, BMI 24.2 ± 0.4 kg/m
conclusionsCompared to US patients, GERD profiles in Asian patients associate with higher symptom reporting despite lower objective reflux burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.